title: Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report.
abstract: The authors present a case of morphologic changes of drusen and drusenoid pigment epithelial detachment (DPED) after treating choroidal neovascularization (CNV) using ranibizumab in age-related macular degeneration (AMD). A 71-year-old woman has noticed mild visual acuity deterioration in the right eye for several months. She was presented with some drusen and DPED associated with CNV. This patient was given intravitreal injection of 0.5 mg of ranibizumab five times at monthly intervals for treating CNV. DPED in the temporal and drusen in the superior to macula were diminished, which continued up to 2 months. Intravitreal ranibizumab injection may have influenced with diminishment of drusen and DPED. After 2 months, CNV was recurred.
authors.affiliation: Department of Ophthalmology, Saevit Eye Hospital, Goyangsi, Korea.
authors.forename: Sukjin
authors.initials: S
authors.lastname: Kim
authors.affiliation: Department of Ophthalmology, Saevit Eye Hospital, Goyangsi, Korea.
authors.forename: Jeongjae
authors.initials: J
authors.lastname: Oh
authors.affiliation: Department of Ophthalmology, Saevit Eye Hospital, Goyangsi, Korea.
authors.forename: Kiseok
authors.initials: K
authors.lastname: Kim
keywords: Age-related macular degeneration; anti-VEGF (vascular endothelial growth factor); drusen; drusenoid pigment epithelial detachment; ranibizumab